CTT Pharmaceutical Holdings, Inc. (CTTH)

CTTH Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2014	FY 2014
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2014	Feb 28, 2014
Market Capitalization	3	4	3	1	9	-
Market Cap Growth	-6.03%	15.15%	113.42%	-84.23%	-	-
Enterprise Value	3	4	3	1	9	-
Last Close Price	0.05	0.06	0.06	0.03	0.49	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2014	FY 2014
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2014	Feb 28, 2014
PB Ratio	68.94	64.13	95.43	23.97	6.11	-
P/TBV Ratio	-	-	-	-	6.11	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2014	FY 2014
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2014	Feb 28, 2014
Debt / Equity Ratio	0.46	0.34	0.53	0.18	0.06	-0.64
Net Debt / Equity Ratio	0.28	0.06	0.52	0.18	0.00	-0.63
Net Debt / EBITDA Ratio	-0.07	-0.03	-0.07	-0.30	-	-
Quick Ratio	0.20	0.50	0.00	-	0.51	0.01
Current Ratio	0.20	0.50	0.00	-	6.19	0.01
Return on Equity (ROE)	-	-357.04%	-542.69%	-	-91.85%	-
Return on Assets (ROA)	-	-99.53%	-205.28%	-	-	-4433.77%
Return on Capital Employed (ROCE)	-436.60%	-229.90%	-777.50%	-59.50%	-44.50%	51.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2014	FY 2014
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2014	Feb 28, 2014
Earnings Yield	-7.42%	-4.41%	-8.15%	-2.93%	-7.36%	-
Buyback Yield / Dilution	-15.38%	-9.92%	-3.65%	-209.26%	-6435.55%	98.32%

Data Source: S&P Global Market Intelligence Last updated: May 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 5, 2026

Data Sources Report a data error